Eton Pharma (ETON) to Report Q4 Earnings: What's in the Cards? [Yahoo! Finance]
Eton Pharmaceuticals, Inc. (ETON)
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Eton is a commercial-stage company with four approved products, Alkindi Sprinkle, Carglumic Acid, Betaine Anhydrous and Nitisinone Capsules, in its portfolio at present. Alkindi Sprinkle and Carglumic Acid sales are primary contributors to the top line. Betaine Anhydrous, launched in May 2023, has also been witnessing solid uptake. ETON's earnings surpassed expectations in each of the trailing four quarters, delivering an average earnings surprise of 177.14%. In the last reported quarter, the company recorded a positive earnings surprise of 80%. In the past year, shares of Eton Pharma have gained 20.5% against the industry's 7% decline. Image Source: Zacks Investment Research Let us see how things have shaped up for the quarter to be reported. Factors to Consider Eton recognizes revenues under two heads in its income statement — Licensing revenues and Product sales and royalties. The company's fourth-quarter revenues are likely to have been driven by the sales of its ma
Show less
Read more
Impact Snapshot
Event Time:
ETON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ETON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ETON alerts
High impacting Eton Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ETON
News
- Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals Reports First Quarter 2024 Financial ResultsGlobeNewswire
- Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $8.00 price target on the stock.MarketBeat
ETON
Earnings
- 3/14/24 - Miss
ETON
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/30/24 - Form 8-K
- ETON's page on the SEC website